LMAT - LeMaitre Vascular, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.67
|
Rev Est: $62.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$101.50
DETAILS
HIGH:
$108.00
LOW:
$95.00
MEDIAN:
$101.50
CONSENSUS:
$101.50
UPSIDE:
11.85%
Market Cap:
2.06B
Volume:
188,918
Avg Volume:
163,166
52 Week Range:
71.42-105.55
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.70
Last Dividend:
$0.80
Exchange:
NASDAQ
Country:
US
Employees:
651
IPO Date:
2006-10-19
EPS (TTM):
1.96
P/E Ratio:
46.98
Revenue (TTM):
219.86M
Total Assets:
551.82M
Total Debt:
185.69M
Cash & Equiv:
25.61M
Rev Growth (5Y):
13.4%
EPS Growth (5Y):
16.6%
FCF Growth (5Y):
28.9%
ROCE:
11.0%
Debt/Equity:
0.55
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.62 | $0.56 | +9.9% | $61.0M | $62.2M | -1.8% |
| 2025-08-05 | $0.60 | $0.57 | +5.3% | $64.2M | $60.9M | +5.5% |
| 2025-05-01 | $0.48 | $0.50 | -4.0% | $59.9M | $57.6M | +3.9% |
| 2025-02-27 | $0.49 | $0.49 | 0.0% | $55.7M | $56.0M | -0.5% |
| 2024-10-31 | $0.49 | $0.44 | +11.4% | $54.8M | $56.0M | -2.1% |
| 2024-08-01 | $0.52 | $0.47 | +10.6% | $55.8M | $55.0M | +1.6% |
| 2024-05-02 | $0.44 | $0.39 | +12.8% | $53.5M | $51.5M | +3.8% |
| 2024-02-27 | $0.38 | $0.36 | +5.6% | $48.9M | $49.0M | -0.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 219.86M | 193.48M | 161.65M | 154.42M | 129.37M | 117.23M | 105.57M | 100.87M | 89.15M | 78.35M | 71.10M | 64.55M |
| Net Income | 44.04M | 30.11M | 20.64M | 26.91M | 21.22M | 17.93M | 22.94M | 17.18M | 10.59M | 7.76M | 3.92M | 3.20M |
| EPS | 1.96 | 1.36 | 0.94 | 1.27 | 1.05 | 0.91 | 1.18 | 0.91 | 0.57 | 0.44 | 0.24 | 0.21 |
| Total Assets | 551.82M | 346.78M | 310.48M | 292.80M | 252.81M | 188.34M | 153.09M | 126.32M | 101.92M | 90.70M | 81.49M | 70.49M |
| Total Debt | 185.69M | 19.09M | 16.60M | 15.94M | 54.78M | 15.71M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 25.61M | 24.27M | 19.13M | 13.86M | 26.76M | 11.79M | 26.32M | 19.10M | 24.29M | 27.45M | 18.69M | 14.71M |
| Operating Cash Flow | 44.12M | 36.75M | 25.38M | 35.10M | 34.80M | 14.18M | 19.51M | 22.87M | 16.90M | 11.44M | 5.51M | 5.39M |
| Free Cash Flow | 37.16M | 29.49M | 22.15M | 30.22M | 31.82M | 10.42M | 16.45M | 16.45M | 14.05M | 9.15M | 4.32M | 2.49M |
| FCF per Share | 1.66 | 1.33 | 1.01 | 1.43 | 1.57 | 0.53 | 0.85 | 0.87 | 0.76 | 0.51 | 0.26 | 0.16 |
| Book Value | 337.29M | 297.90M | 268.20M | 254.15M | 172.57M | 148.14M | 130.24M | 109.77M | 87.50M | 77.88M | 68.21M | 56.56M |
| Cash & ST Investments | 299.72M | 105.07M | 82.69M | 69.96M | 26.98M | 32.68M | 47.99M | 41.66M | 24.29M | 27.45M | 18.69M | 14.71M |
| ROC Equity | 0.13 | 0.10 | 0.08 | 0.11 | 0.12 | 0.12 | 0.18 | 0.16 | 0.12 | 0.10 | 0.06 | 0.06 |